Eyegate receives patent approvals for delivery system, pharmaceutical formulation

The U.S. Patent and Trademark Office issued a Notice of Allowance for a patent application related to Eyegate Pharmaceuticals’ Eyegate II Delivery System with pre-filled drug applicator, the company announced in a press release.The patent is for a delivery device containing a hydrogel applicator used to transport therapeutic substance across and/or through the eye, the release said.